GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ion Beam Applications SA (OTCPK:IOBCF) » Definitions » Cash Ratio

Ion Beam Applications (Ion Beam Applications) Cash Ratio : 0.24 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Ion Beam Applications Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Ion Beam Applications's Cash Ratio for the quarter that ended in Dec. 2023 was 0.24.

Ion Beam Applications has a Cash Ratio of 0.24. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Ion Beam Applications's Cash Ratio or its related term are showing as below:

IOBCF' s Cash Ratio Range Over the Past 10 Years
Min: 0.15   Med: 0.31   Max: 0.57
Current: 0.24

During the past 13 years, Ion Beam Applications's highest Cash Ratio was 0.57. The lowest was 0.15. And the median was 0.31.

IOBCF's Cash Ratio is ranked worse than
82.67% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 1.23 vs IOBCF: 0.24

Ion Beam Applications Cash Ratio Historical Data

The historical data trend for Ion Beam Applications's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ion Beam Applications Cash Ratio Chart

Ion Beam Applications Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.55 0.57 0.37 0.24

Ion Beam Applications Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.51 0.37 0.24 0.24

Competitive Comparison of Ion Beam Applications's Cash Ratio

For the Medical Devices subindustry, Ion Beam Applications's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ion Beam Applications's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Ion Beam Applications's Cash Ratio falls into.



Ion Beam Applications Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Ion Beam Applications's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=119.2/493.567
=0.24

Ion Beam Applications's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=119.2/493.567
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ion Beam Applications  (OTCPK:IOBCF) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Ion Beam Applications Cash Ratio Related Terms

Thank you for viewing the detailed overview of Ion Beam Applications's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ion Beam Applications (Ion Beam Applications) Business Description

Traded in Other Exchanges
Address
Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and the Rest of the World, with REst-of-World sales generating the largest proportion of revenue.

Ion Beam Applications (Ion Beam Applications) Headlines

From GuruFocus

Q4 2021 Ion Beam Applications SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2023 Ion Beam Applications SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Ion Beam Applications SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2019 Ion Beam Applications SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2019 Ion Beam Applications SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Ion Beam Applications SA Earnings Call Transcript

By GuruFocus Research 02-14-2024